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ABSTRACT
A plethora of catheter-based strategies have been developed to treat mitral valve disease. Evolving 3-dimensional (3D)
multidetector computed tomography (MDCT) technology can accurately reconstruct the mitral valve by means of
3-dimensional computational modeling (3DCM) to allow virtual implantation of catheter-based devices. 3D printing
complements computational modeling and offers implanting physician teams the opportunity to evaluate devices in
life-size replicas of patient-specific cardiac anatomy. MDCT-derived 3D computational and 3D-printed modeling provides
unprecedented insights to facilitate hands-on procedural planning, device training, and retrospective procedural evalu-
ation. This overview summarizes current concepts and provides insight into the application of MDCT-derived 3DCM and
3D printing for the planning of transcatheter mitral valve replacement and closure of paravalvular leaks. Additionally,
future directions in the development of 3DCM will be discussed. (J Am Coll Cardiol Img 2021;-:-–-) © 2021 by the
American College of Cardiology Foundation.
P re-procedural planning with 3-dimensional(3D) multidetector computed tomography(MDCT) has proven to be a prerequisite plan-
ning tool for successful transcatheter aortic valve
replacement (TAVR) in elderly patients with degener-
ative tricuspid aortic valve stenosis (AS) who are at
elevated operative risk (1).
A plethora of catheter-based strategies aim to tackle
mitral valve defects. Whereas the aortic root arguably
represents a relatively straightforward tubular
structure, the mitral valve features a more complex
confluence of surrounding structures and introduces
patient-specific particularities. This requires
individualized advanced planning. Traditionally,
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echocardiography has been the mainstay
of imaging. However, there are limitations
to using single-modality imaging for trans-
catheter pre-procedural evaluation. Two-
dimensional echocardiography is often
unable to visualize the trajectory for intra-
cardiac devices in relation to surrounding
anatomic structures. 3D transesophageal
echocardiography (TEE) has limited spatial
resolution and may be hampered by dropout
artifacts that may mimic perforations or
leaks (2). It is this spatial resolution that is
essential in complex catheter-based mitral
interventions, as it enables adequate device
sizing and detailed assessment of the valve
and its surroundings.
Improvements in MDCT spatial resolution,
acquisition speed, and reconstruction algo-
rithms enable the derivation of accurate
virtual 3D reconstructions of cardiac struc-
tures to virtually test catheter-based
procedures. Compared with echocardiography and
cardiovascular magnetic resonance imaging (CMR),
MDCT has superior spatial resolution and allows
for isotopical imaging. 3-dimensional printing
(3Dp), based upon MDCT-derived 3D computational
models, complements virtual modeling and offers the
opportunity to implant devices in life-sized casts of
the cardiac anatomy (3). The 3D-printed modeling
facilitates hands-on procedural planning, device
training, and retrospective procedural evaluation.
Ultimately, physicians may better understand a
patient’s unique anatomy and can bench test future
catheter-based interventions (4–6). A clear distinction
has to be made between 3D computational models
and simulation, the latter using tissue/device prop-
erties and their respective interactions to predict
structural/functional outcome. Furthermore, by add-
ing computational fluid dynamics to these models,
blood flow is simulated (7).
Herein, we provide a comprehensive overview of
MDCT-derived 3D modeling in transcatheter mitral
valve procedures including computational (virtual)
modeling and printing. We place this technology in
the perspective of transcatheter mitral valve
replacement (TMVR) and mitral paravalvular leakage
(PVL) closure
BASIC PRINCIPLES OF MDCT-DERIVED 3D
COMPUTATIONAL MODELING
The cornerstone of MDCT-derived 3D computational
modeling (3DCM) and 3Dp is based upon the
following individual guidelines for MDCT-
acquisition, segmentation, and understanding of the
proposed cardiac intervention using available cardiac
imaging applications (4,8).
MDCT ACQUISITION. A detailed overview of MDCT
image acquisition is beyond the scope of this paper, but
in general, MDCT 3D modeling requires contrast-
enhanced, electrocardiography-gated MDCT acquisi-
tion without too stringent electrocardiographic dose
modulation. Iodinated contrast is injected intrave-
nously at a rate of #4 ml/s. However, this may vary, as
protocols between scanners, hospitals, and patients
differ. The use of a saline/contrast flush should be
determined based on indication. Image reconstruction
should be performed for the entire cardiac cycle at 5%
to 10% increments of the R-R interval resulting in 10 to
20 datasets per cardiac cycle. The reconstructed slice
thickness should be <1 mm. Depending on the intra-
cardiac region of interest and the procedure to be
performed, specific phases in the cardiac cycle are
selected for segmentation. The mid to late diastolic
phase is required for maximal mitral annulus di-
mensions. Conversely, annular dimensions in the mid
to late systolic phase are required for minimal mitral
annular dimensions (8).
IMAGE SEGMENTATION. Image segmentation is a
process in which an anatomic label is assigned to a set
of pixels that share similar characteristics. Geometric
analysis and sizing become possible as different
anatomic structures emerge in the digital image.
MDCT is the only modality able to isotopically image
the heart, meaning that volume pixels (voxels) are
identical in size in the x, y, and z planes. Manual
segmentation of cardiac chambers, valves, and great
vessels is time-consuming and has high interobserver
variability. Specialized software packages offer (semi)
automated segmentation processes (9,10) (Figure 1). In
semiautomated segmentation, users label the cardiac
structures and indicate thresholds for the gray value
range in which those structures are optimally visual-
ized. With this input, segmented 3D models of the
heart chambers and great vessels are automatically
obtained from MDCT images using either volume
rendering (VoR) or computational modeling (CM)
(Figure 2). In VoR, a grid of voxels is visualized using
transparency and coloring. In CM, voxels are used to
derive a mesh structure of a multitude of triangles (the
amount depends on the level of convexity and detail
requested). Although a VoR model allows rapid visu-
alization of the grayscale in 3D, it has limited capabil-
ities for downstream operations such as automated
quantification. CM enables automated analysis of
anatomic structures, provides enhanced spatial
insight, and can be converted to a 3D-printed model. A





3Dp = 3-dimensional printing
LA = left atrium/atrial
LV = left ventricle/ventricular
LVOT = left ventricular outflow
tract
LVOTO = left ventricular
outflow tract obstruction




PVL = paravalvular leakage
THV = transcatheter heart
valve
TMVR = transcatheter mitral
valve replacement
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3D computational model can be converted to files with
different extensions, serving different purposes. For
example, the model might be saved as a stereolitho-
graphic file (.STL), facilitating 3Dp, or as an object file
(.OBJ), enabling assessment in virtual reality. Most
models in this paper are created using the CMmethod;
alternative techniques are highlighted where appli-
cable. Once cardiac structures are virtually modeled, a
broad spectrum of clinical applications becomes
available, including assessment of ventricular and
atrial dimensions, characterizing heart defects, pro-
cedural planning, and the design and geometric vali-
dation of medical devices (10–13).
Various (semi)automated segmentation packages
are available including but not limited to: Mimics
Innovation Suite, 3D Slicer, Vitrea, TeraRecon,
3Mensio, Solidworks, and Vascular Modeling Toolkit
(4). In this paper, the Mimics software package
(Materialise NV, Leuven Belgium) was used unless
stated otherwise.
GENERAL CONCEPTS IN 3D COMPUTATIONAL
MODELING. Sizing an asymmetrical 3D orifice. As
existing devices in structural heart disease are
generally symmetrical and available in specific sizes,
the key to pre-operative assessment is to match
asymmetrical patient anatomy with symmetrical de-
vice shape. Sizing an asymmetrical 3D orifice can be
challenging, and 2 methods are generally used.
The conventional method uses MDCT images (axial
thin sections) to obtain a plane at the level of basal
insertion of the mitral leaflets into the mitral annular
ring creating a hinge-point during the mid to late
diastolic phase of the ventricular cycle. Subsequently,
using the double oblique view, the mitral annular
dimensions are captured. This completely manual
technique, which is de facto planimetry, relies
heavily on operator experience to provide the accu-
rate annular size and landing zone for a virtual
transcatheter heart valve (THV) (10) (Figures 2A and
2B). This technique does not accurately reflect the 3D
structure of the saddle-shaped mitral annulus. Its
height, in particular, is challenging to incorporate.
In an alternative VoR-based method, the analyst
tracks the mitral annulus using reference points in
multiple planes around a user-defined center point
(centrally located in the mitral orifice), which creates a
3D reconstruction of the mitral annulus (Figures 2C and
2D). In a method based on 3DCM, mesh models of the
left atrium (LA), left ventricle (LV), and calcium (if
present) are used to position mitral annular reference








(A) Processed multidetector computed tomography (MDCT) images are loaded into specialized segmenting software. (B) Using dedicated
software packages, essential cardiac structures such as the aorta (red) and left ventricle (pink) are marked after which the software semi-
automatically identifies the MDCT-rendered volumes of the aorta, left ventricle, left atrium, and pulmonary vessels (purple). From these data,
segmented 3-dimensional (3D) computational models of the heart chambers and great vessels are automatically obtained. (C) The whole
heart MDCT-derived 3D computational model can be printed or virtually assessed.
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points (Figures 2E and 2F). From these references,
dedicated software constructs a smooth 3D virtual
annulus derived from a series of Fourier approxima-
tions for each of the spatial coordinates (x, y, z) (sem-
iautomated). The contour of the annulus is then
projected onto its best-fit plane, which is calculated
using the least squares method (14) (Figure 2D). This
projected annulus is used to derive the annular area
and diameters. Consequently, the best-fit plane serves
as the landing zone for the virtual THV implant.
Compared with the conventional method in general,
both the VoR and the 3D computational method allow
for a 3D reconstruction of the mitral annulus. 3DCM
further provides a full mesh model of the surrounding
structures allowing detailed assessment of asymmet-
rical structures in a sole model. Furthermore, it en-
ables semiautomated measurement of asymmetrical
structures, volumes, and orifices reducing variability
and potentially lessening processing time.
Virtual device implantation. MDCT-derived 3DCM al-
lows fitting of a geometric shape or a digitalized 3D
virtual device. An empirical starting point for device
and size selection is the area-derived diameter of the
reconstructed annulus or orifice. The selected device
is automatically centered around the geometric
midpoint of the best-fit plane. Given the asymmet-
rical shape of anatomic structures, it is essential to
visually assess fitting of the device in multiple angles.
Spatial interaction with surrounding structures can
also be tested, thereby identifying possible malap-
position or obstruction (9) (Figure 3). This concept of
an adequate visual fit is essential in MDCT-derived
3DCM, but lacks any appreciation of tissue and de-
vice characteristics to interpret device-host in-
teractions. Specialized models that incorporate tissue
and device properties in virtual models are under
development and have reasonable accuracy in TAVR
simulation of implants and prediction of residual




(A) Conventional sizing method: Cross-sectional view of the left heart including the large left atrium, left ventricle, and aortic valve prosthesis. The orange line
represents the double oblique view visualized in B. (B) Axial thin section of the mitral annulus demonstrating severe mitral annular calcification. The red ellipse is
manually fitted onto the annulus, allowing derivation of the maximal and minimal annular diameters. (C) Volume rendering method: a 3D annulus was created around a
user-defined center point (yellow dot). (D) Atrial view, annular dimensions were: area derived Ø 26 mm, max. Ø 31 mm, min. Ø 20 mm. (C and D) Images were obtained
with the 3Mensio software package. (E) 3D computational modeling method: a MDCT-derived 3D computational model of the left ventricle (pink) and mitral annular
calcification (yellow) allows semiautomated mitral annulus tracing (white reference points and green line). (F) Using reference points, a 3D virtual mitral annulus is
computed and used to compute the best-fit plane (orange lines) and associated annular dimensions (area derived Ø 23 mm, max. Ø 30 mm, min. Ø 16 mm). (E and F)
Images were obtained with the Mimics software package. All images originate from the same MDCT scan. Abbreviations as in Figure 1.
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paravalvular leaks, conduction disorders, and cal-
cium displacement (7,15).
3D PRINTING
MDCT-derived 3D computational models incorporate
spatial relationships on a 2-dimensional screen and
might impair complete understanding of the detailed
3D reality. Consequently, a full understanding of the
model requires meticulous and time-consuming
assessment from multiple angles. However, trans-
formation of these computational (virtual) models
into physical form by means of 3Dp can resolve these
limitations. The availability of a patient-specific
physical model can facilitate medical teaching,
exploration of valve function, and pre-procedural
planning (11). In congenital heart disease, 3Dp has
been shown to be helpful in pre-procedural planning
of surgical correction (16). Subsequently, this tech-
nique has been gradually adopted to help plan
different catheter-based interventions for structural
heart disease (4). In the mitral space, 3Dp models
have been instrumental in the identification of de-
fects, device sizing, and procedure execution
(Figure 4) (11,17)
A recent systematic review on 3Dp in adult heart
valve disease identified MDCT as the first choice
modality for 3Dp (62%), followed by ultrasound
(28%), computer aided design with separate manual
creation of model parts (7%), and CMR (3%) (4). MDCT
offers excellent spatial resolution, allowing clear
depiction of pathological calcium and does not
generally require image quality adjustment before
anatomic segmentation (17). The TEE-derived 3Dp is
limited by suboptimal detection of the subvalvular
apparatus, left ventricular geometry, tissue differen-
tiation, or calcium deposits. Additionally, because
spatial resolution of ultrasound is best along the
longitudinal plane, views from different angles need
to be fused to capture 2 perpendicularly aligned
structures and master resolution issues. Resolution is
also limited by the probe-specific properties of the
piezoelectric crystal. Ultimately, TEE does not allow
for isotropic imaging and is therefore less suitable for
3Dp. CMR avoids radiation exposure and has excel-
lent tissue characterization abilities, but is hampered
by inferior spatial resolution that may impair detec-
tion of small intracardiac defects. However, it has
been successfully applied to 3D-printed modeling in
congenital heart disease (8).
3D-printed models in cardiovascular disease are
typically composed of a variety of rigid and/or flexible
materials (4,18,19). Rigid material, such as poly-
butylene terephthalate, acrylonitrile-butadiene sty-
rene, and polyamide, are suited for mimicking
prostheses and calcium. They can also be used if the
goal of the print is to acquire complementary
anatomic insight (educational purposes), regardless









(A) MDCT-derived 3D computational modeled reconstructions of the left atrium (LA) and pulmonary veins (purple), mitral annular calcification (MAC) (yellow), left
ventricle (LV), and aorta (red). The mitral annulus is traced with green dots. MAC is used as a reference point for virtual annular construction (green line). (B) Surgical
view of the same calcified mitral annulus. (C) Virtual implantation of a cylinder representing a 23-mm Sapien3 transcatheter heart valve (THV) (Edwards Lifesciences,
Irvine, California). Abbreviations as in Figure 1.
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of any appreciation of tissue characteristics. Flexible
materials, including, but not limited to, thermoplastic
elastomers (i.e., Tango Plus, Agilus, HeartprintFlex)
and printable silicones, are increasingly developed to
mimic human tissue and are more suitable for fitting
actual devices. Other materials, such as resins, can be
used to yield either solid or flexible models depend-
ing on the printing technique used. By combining
materials of different rigidity in 1 3D-printed model,
valve calcification or the presence of a prosthetic
valve can be replicated.
In practice, both healthy and diseased native valve
tissue is highly heterogeneous with variable physical
properties (20). Currently available 3Dp material does
only slightly approach the properties of arterial tis-
sue, and is still far away from reliably representing
the human heart (17). The mechanical properties of
the ideal printed model would resemble tissue-
specific characteristics under different circum-
stances. In reality, however, a trade-off between
practicality and cost determines the final 3D print. As
such, 3Dp of the heart is still in its infancy and under
further development.
CLINICAL APPLICATIONS OF 3D COMPUTATIONAL
MODELING: TRANSCATHETER MITRAL
VALVE REPLACEMENT
Mitral regurgitation and mitral stenosis are the sec-
ond and third most frequent clinically relevant valve
diseases (21). The advent of catheter-based
techniques for mitral repair and replacement presents
new treatments for a significant number of patients
who would otherwise be denied conventional surgery
(21). TMVR is beset by complex anatomic challenges,
including its central cardiac location; elliptical,
saddle-shaped annulus; and associated chordal
apparatus. Additionally, it introduces the risk of left
ventricular outflow tract (LVOT) obstruction (22,23)
and valvular foreshortening in the LA. TMVR can be
performed in previously surgically implanted annular
rings, bioprostheses, and the native annulus (24–26).
A failing bioprosthesis, mitral ring, or excessive
mitral annular calcification may provide anchoring
opportunities for THV designs that were originally
developed for aortic valve implantation (24,27). In the
native noncalcified mitral annulus, the implanted
valve uses other anchor opportunities and typically
dominates its direct surroundings, which has conse-
quences for the risks of PVL and left ventricular
outflow tract obstruction (LVOTO). To address this,
multiple dedicated designs for TMVR are under
development or have entered clinical trials (25,28).
MDCT-derived 3DCM may prove particularly helpful
for TMVR, as various TMVR sizes and designs can be
evaluated in virtual implants, generating information
to enhance procedural efficacy and patient safety.
VIRTUAL ANNULUS CREATION AND VALVE SIZING.
A surgical prosthesis is traceable on MDCT planim-
etry. Additionally, implanted prosthesis type and size
can be deducted from these images, leading to a











(A) MDCT-derived, 3D-printed model of the left heart with a 26-mm Sapien3 prosthesis implanted in the mitral annulus allowing for detailed
evaluation of the expected neo-left ventricular outflow tract from a left ventricular viewpoint. (B) Surgeon’s view of the left atrium of a 3D-
printed model in which occluder devices are positioned along the frame of a bioprosthetic mitral valve. THV ¼ transcatheter heart valve; other
abbreviations as in Figure 1.
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relatively straightforward THV sizing and provision of
a ready-made best-fit plane (29). However, blooming
artifacts may affect measurements (30). Sizing the
native mitral annulus (with/without annular calcium)
proves more challenging as its borders are asymmet-
rical and less pronounced. In such cases, planimetry
may omit important information. Additionally, the
native annulus varies in size during the cardiac cycle,
which warrants careful selection of cardiac phase
when creating and measuring the virtual annulus. Its
complex shape and close relation with the ventricle
ideally require virtual 3D reconstruction as described
in the section “General concepts in 3D computational
modeling.”
In the native mitral annulus, the trigone-to-trigone
connection represents an additional landmark in this
process (31). If necessary, subtle adjustments in the
virtual mitral annulus shape can be made. The original
annular anatomy may be severely distorted by mitral
annular calcification (MAC), allowing limited use of
common structural landmarks (9). However, calcifica-
tion can be used as a landmark for annular sizing. In
MDCT-derived 3DCM, calcium is segmented as a
separate structure and integrated in the structural
model, thereby facilitating virtual reconstruction of
the mitral annulus (Figures 2E, 2F, and 3). Still, caution
must be taken with annulus reconstruction based on
MAC, as calcium may cause blooming artifacts and
potentially affect adequate prosthesis sizing (32).
The virtually reconstructed mitral annulus facili-
tates automated calculation of the reference plane
(best-fit plane, “General concepts in 3D computa-
tional modeling” section) on which a virtual pros-
thetic valve can be projected. Selecting multiple valve
sizes/types, and shifting their position within the
reconstructed annulus, helps to obtain an adequate
visual fit (Figure 3C). However, as this is a virtual
model without incorporation of tissue and device
characteristics, in vivo malapposition still poses an
important risk, especially in MAC (33).
NEO-LVOT. TMVR may cause LVOT deformation as a
result of strut protrusion and anterior mitral leaflet
(AML) displacement (34). This leads to the formation
of a new elongation of the native LVOT, which is
referred to as the neo-LVOT (35). Acquired LVOTO
(narrow/blocked neo-LVOT) is associated with
procedure-related death, conversion to surgery, or
emergency percutaneous reintervention (22). MDCT-
derived 3DCM can estimate the neo-LVOT using
various valves with different implantation heights,
guiding TMVR (35).
According to the latest Mitral Valve Academic
Research Consortium criteria, LVOTO is classified as
an increase in LVOT gradient of $10 mm Hg compared
with baseline (36). In previous studies, which used
MDCT for prediction of the minimal neo-LVOT area, 2
methods of neo-LVOT estimation were described. In 2
reports, manual planimetry was performed on cross-
sectional images with a THV projected on the mitral
annulus in the mid to late systolic phase, when the
neo-LVOT area is smallest (22,35). Using this method,
the suggested cut-off value for the neo-LVOT area
with greatest discriminatory value for LVOTO
was #170.0 mm2 (22).
The other method uses an MDCT-derived 3D
computational model of the left heart with a virtual
THV implant that allows semiautomated calculation
of the minimal neo-LVOT area through volumetric
assessment. With the neo-LVOT identified, its 3D
relation to the implanted THV, LV, and original LVOT
becomes clear. Repeated fitting using various virtual
implants and manipulating device type, size, cardiac
phase, implant depth, and co-axiality within the
mitral annular plane is possible (Figure 5). Because
volumetric data concerning the LV and THV can be
derived from the computational model, obstruction
can be expressed as a fraction of the original LVOT.
Other predictors for LVOTO in TMVR, such as the
angle between the native LVOT and aorta, AML
length, and septal wall thickness, may be evaluated in
these models, allowing review of complex 3D struc-
tures in different hypothetical situations (22,37).
Furthermore, strategies can be planned to tackle
projected obstruction (e.g., simultaneous LVOT
balloon inflation, LVOT post-dilatation, or alcohol
septal ablation). As such, the model serves as a
patient-specific, virtual training ground allowing se-
rial testing prior to the planned high-risk procedure
without clinical consequences. A study using this
method found a cut-off value for the MDCT-derived
neo-LVOT area of #189.4 mm2 to have the greatest
discriminatory value for post-TMVR LVOTO (9).
Direct comparisons of the clinical accuracy of
neo-LVOT prediction in pre- and post-TMVR MDCT
datasets using 3D computational models have
demonstrated excellent correlation with high repro-
ducibility and accuracy (9). Comparing predicted and
post-TMVR neo-LVOT by manual planimetry of MDCT
images has also shown reproducibility with low
intraobserver and interobserver variability (22). Of
note, performance of neo-LVOT prediction with
MDCT planimetry and semiautomated MDCT-derived
3DCM have yet to be compared.
MULTIPHASE PLANNING IN LVOT ASSESSMENT.
As experience with LVOTO in TMVR expands, it be-
comes evident that pre-procedural planning based on
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a single cardiac phase might be too crude. As LVOT
dimensions are smallest in the end-systole, around
40% of the R-R interval, any geometric LVOTO after
TMVR would first occur in that phase. However, the
vast majority of the stroke volume is ejected in the
early and mid-systolic phase, implying that a func-
tional, clinically relevant LVOTO should occur at that
time. A report on pre-procedural multiphase neo-
LVOT assessment in screening for TMVR using a
dedicated THV showed that patients with predicted
end-systolic obstruction performed well after TMVR
when there was no predicted early systolic obstruc-
tion (38). These findings underpin the relevance of a
multiphase approach when evaluating TMVR eligi-
bility. The creation of full-cycle MDCT-derived 3D
computational models, or 4D computational models,
will add to effective patient/device selection in
TMVR.
EVALUATING THE TRANSSEPTAL APPROACH.
Transvenous transseptal TMVR is less invasive than
the transapical approach and rapidly becoming the
access strategy of first choice (25). Superior and












Atrium 40% : Ventricle 60% 
Atrium 55% : Ventricle 45% 
(A, right) MDCT-derived 3D computational model of the left ventricle (LV) with severely calcified mitral annulus (yellow) in a medio-lateral
view. (Left) The same model viewed from the aorta. A virtual cylinder representing a 23-mm Sapien3 transcatheter heart valve (THV) was
implanted at a 40/60 position. The neo left ventricular outflow tract (neo-LVOT) (blue circle, left; blue asterisk, right) is automatically
calculated and has an area of 138 mm2 (58% native LVOT occupancy). (B) The same LV model as in A with THV implanted at a 55/45 position.
The calculated neo-LVOT area is 162 mm2 (39% native LVOT occupancy). Abbreviations as in Figure 1.
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posterior puncture through the interatrial septum
facilitates catheter manipulation in the LA for device
orientation and positioning within the mitral appa-
ratus. MDCT can provide a roadmap and help deter-
mine optimal C-arm angles that may be fused with
live fluoroscopic imaging (39). MDCT-derived 3D
computational models enhance appreciation of the
anatomic relations among the inferior vena cava,
interatrial septum, and mitral annulus. Additionally,
by printing a 3D model of the right atrium, LA, and
mitral annulus, the operator can undertake hands-on
assessment of the transseptal puncture site. The
optimal puncture site can be pre-determined fol-
lowed by evaluation of the consequences for catheter
manipulation when approaching the mitral valve.
Furthermore, catheters can be tested in terms of
flexibility, crossability, and deliverability toward the
region of interest.
OPTIMAL FLUOROSCOPIC PROJECTIONS. Efforts have
been made to determine MDCT-derived optimal
fluoroscopic projections for TMVR (40). However,
adequate visualization of the mitral annulus some-
times requires impractical angles in the catheter lab-
oratory setting. Furthermore, optimal projections are
device-specific and vary greatly between subjects.
MDCT-derived 3DCM helps to compromise and
determine the best workable fluoroscopic views for
the respective TMVR-related manipulations (Supple-
mental Figure 1). Determining optimal projections
prior to procedure commencement potentially re-
duces fluoroscopy time and therefore radiation
exposure as well as contrast dosage (41).
PLANNING WITH DEDICATED DEVICES. Numerous
dedicated devices that have proprietary anchoring
mechanisms with unique spatial orientations in the
LA, LV, and LVOT are being developed for TMVR (25).
Planning TMVR with MDCT-derived 3D computa-
tional models may add substantially to determining
the appropriate device for an individual patient.
For example, the Tendyne device (Abbott, Abbott
Park, Illinois) utilizes an apical tethering mechanism
for device stabilization (28) (Supplemental Figure 2).
The anchoring zone of the tether is in a coaxial posi-
tion with the LV apex. Deviations from that position
could lead to loss of or excessive traction on the
valve, resulting in suboptimal placement or disloca-
tion of the valve. Identifying the optimal anchoring
zone relies on 3D MDCT imaging with subsequent
confirmation by procedural TEE and manual exami-
nation (42). In MDCT, the mitral annulus is manually
traced using both short- and long-axis views leading
to the formation of a virtual segmented annulus.
From this 3D annulus, a best-fit annular plane is
computed using the least-squares method. This plane
can be used to derive the geometric centroid of the
mitral annulus (Supplemental Figure 2A). The ideal
anchoring point is obtained by drawing a line
perpendicular to the annular plane down to the
epicardium of the LV. The suggested anchoring point
for the tether is referred to as the orthogonal LV ac-
cess point (Supplemental Figures 2B to 2D) (43). Once
the anchoring site is determined, the device can be
virtually implanted and assessed for adequate fit and
relation to the LVOT. 3D modeling provides an over-
view of complex interlinked structures that deter-
mine suitability for a dedicated THV.
CLINICAL APPLICATIONS OF 3D
COMPUTATIONAL MODELING: MITRAL
PARAVALVULAR LEAKAGE CLOSURE
Significant prosthetic PVL after surgical mitral valve
replacement is relatively common and reported in up
to 17% of patients at 15 years of follow-up (44). Risk
factors include annular calcification, infection, suture
technique, tissue integrity, and myocardial contrac-
tion (45).
Echocardiography is the first step to reveal PVL
location and quantification (46). Accurate orifice
sizing is difficult as a result of dropout artifacts and
may lead to underestimation of severity. Pre-
procedural MDCT assessment helps define PVL
characteristics, strategy planning, and device/size
selection. All MDCT imaging is associated with
blooming and device-related artifacts that may
impede accurate evaluation of valve integrity or leak
sizing (12,47). However, when MDCT data is
segmented to create a 3D model, it has the potential
to partially bypass excessive artifacts (at the cost of
variability). MDCT-derived 3DCM and virtual trans-
catheter closure device may improve accuracy and
offer complementary insights into interstructural re-
lations and sizing.
Determination of the cardiac phase is essential for
PVL analysis and is in systole for mitral PVL. Finding
the optimal phase is refined by additional TEE infor-
mation (48). To obtain a 3D computational model
from MDCT images, manual segmentation of the
cardiac walls is required based on subtle differences
in pixel gray value of the raw dataset. This is per-
formed in the double oblique setting. From this seg-
mentation, a 3D computational model is created.
After manual adjustment, a patient-tailored model is
created in which prosthesis shadowing and blooming
artifacts are reduced to reveal essential details for
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complex lesion sizing. Additionally, MDCT-derived
3DCM provides information on PVL location in rela-
tion to the inter-atrial septum and determination of
an optimal catheter trajectory. Indeed, such modeling
can determine whether percutaneous PVL closure is
feasible at all (49). However, detailed knowledge
about normal appearances as well as suture
appearances is essential. To further clarify anatomic
relations, the virtual model can be printed allowing
bench testing (Figure 4B).
Figures 6A to 6C provide TEE illustration of PVL
affecting a mechanical prosthetic mitral valve.
Because the dimensions of the leak could not be
adequately appreciated on these images, a




Images are obtained from a patient with a St. Jude 27-mm mechanical mitral prosthesis. (A) Transesophageal echocardiography (TEE) image in the 2-chamber view
showing the mitral valve with no obvious paravalvular defect. (B) The same 2-chamber image with color-Doppler demonstrating a significant paravalvular leakage
(PVL) on the postero-medial side of the prosthesis. (C) 3D-TEE image with color Doppler showing a PVL (green arrow). (D) Pre-procedural, MDCT-derived 3D
computational model of the prosthetic mitral valve from a surgical view in early diastole, the paravalvular defect is apparent on the postero-medial side. (E) Surgical
view of the 3D reconstructed mitral prosthesis—the paravalvular defect measures 9.7  4.0 mm. (F) Based on measurements derived from the model in D and E, a
10  5 mm Amplatzer cardiac plug (Abbott, Abbott Park, Illinois) (red arrow) was selected. (G) Post-implantation TEE with the plug in situ (red arrow) showing
reduced PVL. (H) 3D-TEE with color Doppler of the occluded PVL with the plug visible (red arrow). Abbreviations as in Figure 1.
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complementary MDCT-derived 3D computational
model was obtained, allowing measurements from
different angles to enable appropriate sizing and
closure device selection. Procedural results are
depicted in Figures 6D to 6H.
In our experience, compared with TEE, MDCT-
derived 3DCM provides superior information con-
cerning location, sizing, and structural interactions of




MDCT ACQUISITION. MDCT has its inherent limita-
tions. Its acquisition can be limited by arrhythmias or
low cardiac output resulting in reduced luminal
contrast. Additionally, it exposes patients to neph-
rotoxic contrast and could evoke allergic contrast
reactions. In patients with renal dysfunction, pro-
phylactic fluid administration prior to scan acquisi-
tion might induce variability in loading conditions.
MDCT-derived modeling requires image acquisition
throughout the entire cardiac cycle, and thus comes
with additional ionizing radiation dose exposure.
MDCT-DERIVED 3D COMPUTATIONAL AND PRINTED
MODELS. An MDCT-derived 3D computational model
represents a static model and therefore only approx-
imates real-time cardiac dynamics. Each segmented
model is derived from 1 cardiac phase, which stresses
the importance of adequate phase selection (i.e., ex-
pected dimensions being minimal/maximal).
Currently, MDCT-derived 3D models do not allow for
CENTRAL ILLUSTRATION Pre-Procedural Planning of Mitral Valve Interventions Using
MDCT-Derived 3-Dimensional Virtual and Printed Models
MDCT-derived 3D computational
 model of the left heart
Modeling paravalvular leakage
Modeling of the neo-left ventricular outflow tract







Evaluation of neo-left 
ventricular outflow 








Evaluation of dimensions and
accessiblity
Ooms, J.F. et al. J Am Coll Cardiol Img. 2021;-(-):-–-.
MDCT-derived, 3-dimensional (3D), computational modeling and physical printing generate anatomic insights to help test, plan, and execute
transcatheter mitral valve replacement and paravalvular leakage closure. MDCT ¼ multidetector computed tomography.
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shifting between phases once segmentation has been
performed. Consequently, acquiring a model of the
whole cardiac cycle requires laborious separate model
segmentation and construction of each phase. Auto-
mation in segmentation could solve these issues. 3Dp
relies on a single cardiac phase, making it less suit-
able for the evaluation of dynamic obstruction.
Furthermore, important hemodynamic concepts and
procedural hemodynamic filling status are not
considered in a static model and may result in inac-
curate sizing in vivo. The lack of incorporation of
specific device and tissue properties in current
MDCT-derived geometric models poses a problem
when devices are implanted in real life. Although
virtual device implantation may suggest a proper fit,
in vivo implantation may cause marked tissue shift or
altered device configuration leading to malapposition
or rotation. Moreover, the absence of standardized
protocols for device sizing in virtual 3D models could
lead to interobserver variability. 3D-printed models
are increasingly acquired to assist in pre-procedural
planning of transcatheter structural heart in-
terventions. However, cautious interpretation of
their significance is necessary because these models
still are a relatively raw representation of reality.
Additionally, they lack standardized, reproducible
methods for measuring distances/areas. However,
efforts for structured verification have been made
(50).
FUTURE DIRECTIONS
Several developments could further enhance MDCT-
derived 3D modeling and will contribute to a future
of patient-tailored valve replacement.
INCORPORATION OF TISSUE AND DEVICE PROPERTIES
IN COMPUTATIONAL MODELING. In vivo implanted
devices will affect the geometry/configuration of
surrounding tissue and vice versa (51). Incorporation
of tissue/device mechanical properties and their ge-
ometry and dimensions in a computational model
predicts these geometric/configurational changes
and, thereby, assists in the selection of the optimal
device type and size (7,52). Patient-specific geometry
is obtained from actual patient data (MDCT, CMR, 3D
echo) and used to create a static model. Mechanical
properties are derived from ex vivo stress-strain an-
alyses. These experiments assess the changes in
configuration/dimension of a structure upon expo-
sure of stress. The changes in configuration depend
on the amount and direction of the stress, the
composition, and the reference state of the material
(7,53). Computer modeling and simulation use finite
element analysis to allow modeling of the whole
(complex) structure (20,54,55). In TMVR, several
cases are described in which a finite element model
was used to predict outcome and aid pre-procedural
planning. By incorporation of mechanical properties
of the annulus, its calcium, the leaflets, and the
selected THV, a simulation could be run predicting
valve-fit and potential LVOTO (15,55,56). The current
experience is proof of concept. Larger-scale valida-
tion studies are needed.
COMPUTATIONAL FLOW DYNAMICS AND FLUID-
STRUCTURE INTERACTION MODELING. Incorpora-
tion of computational fluid dynamics (CFD) into
MDCT-derived 3D computational models allows
the assessment and quantification of PVL. These
models can also be used to evaluate the effect of
valve size, type, and depth of implantation on
hemodynamics and therefore, the degree of
functional LVOTO. It should be acknowledged that
the CFD models are based on a number of as-
sumptions such as pressure gradients, viscosity,
and flow characteristics. Laminar and/or turbulent
flow patterns are incorporated (55).
In addition to the above, analysis of the Fluid
Structure Interaction (FSI) can conceptually be used
for the assessment of the effects of the interaction
between a fluid and adjacent structures (i.e., blood
vs. valve/cardiac tissue). Resulting in the analysis of
the changes in flow and flow patterns, pressures, and
the subsequent effects on cardiac structures (53,57).
For instance, it might facilitate prediction of the ef-
fect of dimensional changes in LVOT after TMVR,
inducing a systolic anterior motion of the AML
through pressure differences (Venturi effect) that in
turn affect neo LVOT flow. In addition of the predic-
tion of hemodynamics, FSI may be of particular value
of the assessment of valve durability as (unwanted)
flow patterns may induce endothelial cell changes
(58). Although progress has been made in creating FSI
models of individual components associated with
mitral valve replacement (53,57), full TMVR models
are experimental, are scarce, and cover only part of
the interactions (55).
A TMVR model fully incorporating tissue and de-
vice properties; flow dynamics; fluid-structure inter-
action models; and coupling of LV, LA, and aorta may
further improve hemodynamic prediction after
structural heart interventions and will lead to an ul-
timate form of patient-tailored medicine, in which a
valve is selected (or created) based on individual
simulations (54,59). However, given the complex
nature of these models and the computational power
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required to create them, there is still a long road
ahead for clinical adoption.
BIOPRINTING. Most 3Dp materials aim to mimic
cardiac tissues. However, using actual (vivo) cardio-
vascular tissue might provide a solution for the crude
biomechanical representation of the human heart in
3Dp. 3Dp using vivo tissue is referred to as bioprinting
and the material used for printing is called bioink.
This material comprises a viscoelastic medium
(mostly hydrogels) together with cells. Depending on
the cardiac structure required, bioink is often printed
on a scaffold (3D geometric structure), which can be
either biological or synthetic and could be modelled
according to a patient’s anatomy (60). Although the
recreation of a fully functioning, patient-specific,
biological 3D print of the heart is somewhat futuris-
tic at this point, progress has been made on separate
parts (61,62). Future incorporation of tissue into the
patient-specific anatomy could greatly enhance the
performance and authenticity of physical 3D-printed
models in valvular heart disease leading to increased
reliability in pre-procedural bench testing.
VIRTUAL REALITY AND HOLOGRAPHIC PROJECTION.
3D virtual models are presented on a 2D screen.
Moreover, while 3Dp introduces a true 3D represen-
tation, it is time-consuming, expensive, and limited
by the intrinsic characteristics of the material used
(4). Visualizing virtual 3D models as holograms could
bypass the need for physical printing, while still
assessing the model in 3D space as if it were directly
in front of the viewer (Supplemental Figure 3). Mea-
surements can be made and the optimal strategy
determined (63) while a connection to surgical tools
or catheter wires may allow live integration of the
intended procedure (64).
LIVE FUSION OF IMAGES. Integration or live-fusion
of the MDCT-derived model with fluoroscopy may
further optimize complex structural heart in-
terventions. Fusion of the pre-procedural, 3D MDCT
model and real-time procedural fluoroscopy may
accelerate procedure execution, limit radiation, and
increase safety (i.e., femoral and transseptal punc-
ture, embolic protection placement, and valve
deployment) (65).
CONCLUSIONS
MDCT-derived 3DCM, and physical printing generate
unprecedented anatomic insights to help test, plan,
and execute complex transcatheter mitral valve in-
terventions (Central Illustration). Further research is
needed to establish these advanced techniques in
clinical practice.
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